Introduction

Thyroid crisis is a potentially fatal endocrinological emergency (1-3). Iodinated agents are essential for its treatment because they immediately retard hormone release from the thyroid gland (2, 3). Lugol's solution is an iodinated agent used for the treatment of thyroid crisis (2, 3). It is primarily used in diagnostic tests for esophageal diseases (4). To detect mucosal lesions, Lugol's solution is sprayed via endoscopic techniques. However, since Lugol's solution can cause local mucosal injury, there have been some reports on Lugol's solution-induced hemorrhage
 (5, 6 
Stevens et al examined various concentrations of Lugol's solution (0.5-5%) for esophageal disease investigation, and found that the use of a higher concentration (3-5%) may increase the risk of mucosal complications (8). In addition, Sreedharan et al recommended that a concentration of 1.5% be used (5). As per these previous reports, the patient in the present case was at a high risk of developing mucosal injury because 3% Lugol's solution was used. A more diluted solution should have been administered to prevent local mucosal injury. Sodium thiosulfate solution is recommended for routine use after Lugol's staining in order to prevent mucosal injury, and its effectiveness has been reported (9). In the present case, sodium thiosulfate should have been administered after treatment with Lugol's solution to prevent local mucosal injury. However, sodium thiosulfate neutralizes iodine solutions, and the neutralized iodine is not absorbed by the mucosa (9). Therefore, the use of sodium thiosulfate may reduce the effectiveness of Lugol's solution for the treatment of thyroid crisis.
The typical iodide intake of people in the United States is 100-400 μg/day (2) . The quantity of iodine required to suppress radioactive iodine to < 2% is >30 mg/day (2) . The quantity of iodine required for the treatment of thyroid crisis is reported to vary from 120 to 3,000 mg/day (2, 3 
